Antithymocyte globulin therapy in chronic lung allograft dysfunction
While ATG improved survival, it did not alter lung function decline, affirming the need for prospective randomized studies.
Authors
- Puneet Garcha (ORCID: https://orcid.org/0000-0003-1099-6967)
- Tianshi David Wu (ORCID: https://orcid.org/0000-0003-4906-3232)
- A. Leon-Pena
- Ramiro Fernandez (ORCID: https://orcid.org/0000-0002-0590-3773)
- Gabriel Loor (ORCID: https://orcid.org/0000-0001-9380-761X)
- Gloria Li
- J. Segraves
- Danielle Guffey (ORCID: https://orcid.org/0000-0003-3721-614X)
- Akhilesh Padhye
Institutions
- Michael E. DeBakey VA Medical Center (US)
- Baylor College of Medicine (US)
- Houston Institute for Clinical Research (US)
Publication Details
- Journal
- Frontiers in Transplantation
- Published
- 2025-07-04
- DOI
- https://doi.org/10.3389/frtra.2025.1607678
- Citations
- 1
- Primary Topic
- Transplantation: Methods and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 2.01